Article Details
Retrieved on: 2022-11-23 21:16:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Dr Frank Mathias, currently CEO at Rentschler Biopharma, will join Oxford Biomedica as CEO and Board Director in March 2023.
Article found on: european-biotechnology.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here